Role of the phosphatidylinositol-3-kinase and extracellular regulated kinase pathways in the induction of hypoxia-inducible factor (HIF)-1 activity and the HIF-1 target vascular endothelial growth factor in ovarian granulosa cells in response to follicle-stimulating hormone

Endocrinology. 2009 Feb;150(2):915-28. doi: 10.1210/en.2008-0850. Epub 2008 Oct 9.

Abstract

FSH stimulation of granulosa cells (GCs) results in increased hypoxia-inducible factor (HIF)-1alpha protein levels and HIF-1 activity that is necessary for up-regulation of certain FSH target genes including vascular endothelial growth factor. We report that the role of the phosphatidylinositol (PI)-3-kinase/AKT pathway in increasing HIF-1alpha protein in FSH-stimulated GCs extends beyond an increase in mammalian target of rapamycin-stimulated translation. FSH increases phosphorylation of the AKT target mouse double-minute 2 (MDM2); a phosphomimetic mutation of MDM2 is sufficient to induce HIF-1 activity. The PI3-kinase/AKT target forkhead box-containing protein O subfamily 1 (FOXO1) also effects the accumulation of HIF-1alpha as evidenced by the ability of a constitutively active FOXO1 mutant to inhibit the induction by FSH of HIF-1alpha protein and HIF-1 activity. Activation of the PI3-kinase/AKT pathway in GCs by IGF-I is sufficient to induce HIF-1alpha protein but surprisingly not HIF-1 activity. HIF-1 activity also appears to require a PD98059-sensitive protein (kinase) activity stimulated by FSH that is both distinct from mitogen-activated ERK kinase1/2 or 5 and independent of the PI3-kinase/AKT pathway. These results indicate that FSH-stimulated HIF-1 activation leading to up-regulation of targets such as vascular endothelial growth factor requires not only PI3-kinase/AKT-mediated activation of mammalian target of rapamycin as well as phosphorylation of FOXO1 and possibly MDM2 but also a protein (kinase) activity that is inhibited by the classic ERK kinase inhibitor PD98059 but not ERK1/2 or 5. Thus, regulation of HIF-1 activity in GCs by FSH under normoxic conditions is complex and requires input from multiple signaling pathways.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Cells, Cultured
  • Extracellular Signal-Regulated MAP Kinases / physiology*
  • Female
  • Follicle Stimulating Hormone / pharmacology*
  • Forkhead Transcription Factors / antagonists & inhibitors
  • Granulosa Cells / drug effects*
  • Granulosa Cells / metabolism
  • Hypoxia-Inducible Factor 1 / metabolism*
  • Insulin-Like Growth Factor I / pharmacology
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Ovary / drug effects*
  • Ovary / metabolism
  • Phosphatidylinositol 3-Kinases / physiology*
  • Phosphorylation / drug effects
  • Protein Kinases / physiology
  • Proto-Oncogene Proteins c-mdm2 / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • TOR Serine-Threonine Kinases
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism*

Substances

  • Forkhead Transcription Factors
  • Hypoxia-Inducible Factor 1
  • Nerve Tissue Proteins
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, rat
  • Foxo1 protein, rat
  • Insulin-Like Growth Factor I
  • Follicle Stimulating Hormone
  • Mdm2 protein, rat
  • Proto-Oncogene Proteins c-mdm2
  • Protein Kinases
  • mTOR protein, mouse
  • mTOR protein, rat
  • TOR Serine-Threonine Kinases
  • Extracellular Signal-Regulated MAP Kinases